ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis

PHASE3CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

July 20, 2015

Primary Completion Date

September 29, 2016

Study Completion Date

March 16, 2017

Conditions

Chronic Hepatitis C Virus (HCV)

Interventions

DRUG

ABT-450/r/ABT-267

Tablet

DRUG

ABT-333

Tablet

DRUG

ribavirin

Tablet